Characterization of population genetic structure of hereditary transthyretin amyloidosis in Bulgaria

References

• Luigetti M, Romano A, Di Paolantonio A, et al. Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care. Ther Clin Risk Manag. 2020;16:109–123.
   PubMed Web of Science ®Google Scholar
• Ando Y, Coelho T, Berk J, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.
   PubMed Web of Science ®Google Scholar
• Salvi F, Pastorelli F, Plasmati R, et al. Genotypic and phenotypic correlation in an Italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis. Amyloid. 2012;19(1):58–60.
   PubMedGoogle Scholar
• Mazzeo A, Russo M, Di Bella G, et al. Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in Sicily, an Italian endemic area. J Neuromuscul Dis. 2015;2(s2):S39–S48.
   PubMedGoogle Scholar
• Hellman U, Alarcon F, Lundgren HE, et al. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid. 2008;15(3):181–186.
   PubMed Web of Science ®Google Scholar
• Polimanti R, Di Girolamo M, Manfellotto D, et al. Functional variation of the transthyretin gene among human populations and its correlation with amyloidosis phenotypes. Amyloid. 2013;20(4):256–262.
   PubMed Web of Science ®Google Scholar
• Santos D, Santos MJ, Alves-Ferreira M, et al. mtDNA copy number associated with age of onset in familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry. 2018;89(3):300–304.
   PubMed Web of Science ®Google Scholar
• Alves-Ferreira M, Coelho T, Santos D, et al. A trans-acting factor may modify age at onset in familial amyloid polyneuropathy ATTRV30M in Portugal. Mol Neurobiol. 2018;55(5):3676–3683.
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, et al. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet. 1995;60(6):512–521.
   PubMed Web of Science ®Google Scholar
• Kato-Motozaki Y, Ono K, Shima K, et al. Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus. J Neurol Sci. 2008;270(1–2):133–140.
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, et al. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered. 1993;43(5):288–294.
   PubMed Web of Science ®Google Scholar
• Adams D, Koike H, Slama M, et al. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 2019;15(7):387–404.
   PubMed Web of Science ®Google Scholar
• Parman Y, Adams D, Obici L, et al. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol. 2016;29(1):S3–S13.
   PubMedGoogle Scholar
• Sarafov S, Gospodinova M, Velina VG, et al. Epidemiology of familial amyloid polyneuropathy in Bulgaria. Orphanet J Rare Dis. 2015;10(S1):O2.
   PubMedGoogle Scholar
• Kirov A, Sarafov S, Pavlova Z, et al. Founder effect of the Glu89Gln TTR mutation in the Bulgarian population. Amyloid. 2019;26(4):181–185.
   PubMed Web of Science ®Google Scholar
• Ohmori H, Ando Y, Makita Y, et al. Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy. J Med Genet. 2004;41(4):e51.
   PubMed Web of Science ®Google Scholar
• Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinformatics Online. 2005;1:45–47.
   Web of Science ®Google Scholar
• Marques AM, Ananina G, Costa VP, et al. Estimating the age of the p.Cys433Arg variant in the MYOC gene in patients with primary open-angle glaucoma. PLoS One. 2018;13(11):e0207409.
   PubMed Web of Science ®Google Scholar
• Iorio A, De Angelis F, Di Girolamo M, et al. Most recent common ancestor of TTR Val30Met mutation in Italian population and its potential role in genotype-phenotype correlation. Amyloid. 2015;22(2):73–78.
   PubMed Web of Science ®Google Scholar
• Reeve J, Rannala B. DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics. 2002;18(6):894–895.
   PubMed Web of Science ®Google Scholar
• Marroni F, Cipollini G, Peissel B, et al. Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis. Ann Hum Genet. 2008;72(3):310–318.
   PubMedGoogle Scholar
• Slatkin M. Linkage disequilibrium-understanding the evolutionary past and mapping the medical future. Nat Rev Genet. 2008;9(6):477–485.
   PubMed Web of Science ®Google Scholar
• Pelo E, Da Prato L, Ciaccheri M, et al. Familial amyloid polyneuropathy with genetic anticipation associated to a gly47glu transthyretin variant in an Italian kindred. Amyloid. 2002;9(1):35–41.
   PubMed Web of Science ®Google Scholar
• Rowczenio DM, Noor I, Gillmore JD, et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. 2014;35(9):E2403–E2412.
   PubMed Web of Science ®Google Scholar
• Barreiros AP, Post F, Hoppe-Lotichius M, et al. Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience. Liver Transpl. 2010;16(3):314–323.
   PubMed Web of Science ®Google Scholar
• Durmuş-Tekçe H, Matur Z, Mert Atmaca M, et al. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Neuromuscul Disord. 2016;26(7):441–446.
   PubMed Web of Science ®Google Scholar
• Haagsma EB, Hawkins PN, Benson MD, et al. Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish families. Amyloid. 2004;11(1):44–49.
   PubMed Web of Science ®Google Scholar
• Zaros C, Genin E, Hellman U, et al. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy. Ann Hum Genet. 2008;72(4):478–484.
   PubMed Web of Science ®Google Scholar
• Coelho T, Sousa A, Lourenço E, et al. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet. 1994;31(4):293–299.
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Ikeda S, et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol. 2002;59(11):1771–1776.
   PubMedGoogle Scholar
• Bonaïti B, Olsson M, Hellman U, et al. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance? Eur J Hum Genet. 2010;18(8):948–952.
   PubMed Web of Science ®Google Scholar